Para/endocrine function of the vascular endothelium of healthy pregnant women and pregnant women with preeclampsia and their neonates;Czynność parakrynno/endokrynna śródbłonka naczyń krwionośnych zdrowych ciȩżarnych i ciȩżarnych z EPH gestoza̧ oraz ich noworodków

Polskie Archiwum Medycyny Wewnetrznej

Volumn 105, Issue 4, 2001, Pages 271-278

  Baumert, Malgorzata ^c   Wiȩcek, Andrzej ^c   Kokot, Franciszek ^b   Osuch Jaczewska, Rozalia ^a  

^a Kurator Kliniki Neonatologii

^b Katedra I Klinika Nefrologii   (Poland)

^c NONE

Author keywords

Endothelin; EPH gestosis; Nitric oxide

Indexed keywords

ENDOTHELIN;

ARTICLE; ENDOCRINE GLAND; FEMALE; HUMAN; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; VASCULAR ENDOTHELIUM;

ENDOCRINE GLANDS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0035321849     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mc Carthy A.L., Wolfson R.G., Rapi S.K., Posto L.: Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am. J. Obstet.Gynaecal, 1993, 168, 1323.
2. Rigo J., Beke A., Paoo J.: Neonatal outcome after preterm delivery for preeclamptic. Am. J. Obstet. Gyneacol., 1996, 174, 1080.
3. Bernhein J.: Hypertension in pregnancy. Nephron. 1997, 76, 254.
4. Ghabour M.S., Eis A.L., Brockman D.E., Pollock J.S., Myatt L.: Immunohistochemical characterization of placentral nitric oxide synthase expression in preeclampsia. Am. Obstet. Gynecol., 1995, 18, 45.
5. Magness R.R., Jant N.F.: Control of vascular reactivity in pregnancy to prevent pregnancy induced hypertension: Semin. Perinat.,1994, 18, 45.
6. Nobunaga T., Tukugawa Y., Hashimoto K., Kimura., Matsuzaki N.: Plasma nitric oxide level in pregnant patients with preeclampsia and essential hypertension. Gynecol. Obstet. Invest., 1996, 41, 189.
7. Cines D.B., Pollak E.S., Buck C.A., Redman W.G.: Endothelial cell in physiology and in the pathophysiology of vascular disorder. Blood, 1998, 91, 3527.
8. Smarason AK., Allman K.G., Young D., Redman W.G.: Elevated levels of serum nitrate, a stabile end product of nitric oxide in women with preeclampsia. Br, J. Obstet Gynecol., 1997, 104, 538.
9. Yang D., Lang V., Greenberg S.G., Myatt L.: Elevation of nitrate levels in pregnancy ewes and their fetuses. Am. J. Obstet. Gynecol., 1996, 174, 573.
10. Vallance P., Collier J.: Znaczenie biologiczne i kliniczne tlenku azotu. BMJ, 1994, 309, 453.
11. Boccardo P., Soregardi M., Aille S. i wsp: Systemic and fetal - maternal NO synthesis in normal pregnancy and preeclampsia Br. J. Obstet. Gynecol. 1996, 103, 879.
12. Bulstra-Ramakers M.T., Huisjes H.J., Visser G.H.: The effect of 3g ectosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. B.J. Obstet-Gynaecol., 1994, 102, 123.
13. Oleszczuk J., Leszczyńska-Gorzelak B.: Wykorzystanie kwasu acerylosalicylowego w zapobieganiu gestozie EPH. Gin. Pol. 1998, (suppl. 32).
14. Nova A., Sibai M., Barton R., Mecer M., Mitchell D.: Maternal plasma level of endothelin is increased in preeclampsia. Am. J. Obstet. Gynecol., 1992, 166, 624.
15. Schiff E., Ben-Banich G., Peleg E., Rosenthal T., Alcalaya A.: Immunooreactive ET-1 in normal and hypertension pregnancies. Am. J. Obstet. Gynecol. 1992, 166, 624.
16. Doering T.P., Haller N.A., Montgomery M.A., Freem E.J., Hopkins M.P.: The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. J. Obstet, Gynecol. 1998, 178, 1307.
17. Guevara I., Iwa̧nejko J., Dȩbińska-Kieć A. i wsp.: Determination of nitrite/nitrate in biological material by the simple Griess reaction. Clin. Chim. Acta, 1998, 22, 274.
18. Chang J.K., Roman C., Heyman M.A.: Effect of endothelium - derived relaxing factor inhibition on the umbilical placental - circulation in fetus lambs in utero. Am. J. Obstet. Gynecol., 1992, 166, 727.
19. Beumi M., Morabito N., Aloisi C., Cotroneo D., Anna R.D., Gemelli M.: Endothelin-1 production in umbilical arteries from hypertensive pregnant wo-men. Cardiorenal Dis. Contrib. Nephrol., 1994, 106, 162.
20. Schiffrin E.L.: Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension, 1995, 25, 1135.
21. Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Fukui T.: Plasma immunoreactive endothelin in essential hypertension. Am. J. Med., 1990, 88, 614.
22. Leszczyńska-Gorzelak B., Oleszczuk J., Kamiński K., Szynula D., Gorzelak M., Oleszczuk J.J.: Disturbed nitric oxide/endothelin-1 equilibrum in cultured human placental endotheliocytes in preeclampsia. Gynecol. Obstet. Invest, 1998, 46, 145.
23. Jośko J., Gwóźdź B., Hendryk S.: Rola endoteliny w regulacji napiȩcia ściany naczyń w fizjologii i patologii. Post. Hig Med. Dośw. 1997, 51, 431.
24. Morris N.H., Sooranna S.R., Ramsay B.: Nitric oxide synthase activities in placental tissue from normotensive, preeclamptic and growth retard pregnancies. Br. J. Obstet. Gynecol., 1995, 102, 711.
25. Rust O., Bofill J.A., Zappe D.H., Hall J.E.: The origin of endothelin-1 in patient with severe preeclampsia. Obstet. Gynecol., 1997, 89, 754.
26. Hasegawa J., Sagawa W., Nanno Y., itoh A.A.: Endothelin-1-like immunoreactivity and endothelin receptors in the human placenta from normotensive and hypertensive pregnancies. J. Perinat. Med., 1996, 24, 451.
27. Di Iorio R., Marinoni E., Emiliani S., Villaccio B., Cosmil E.V.: Nitric oxide in preeclampsia: lack of evidence for decreased production. Eur. J. Obstet Gynecol. Reprod. Biol., 1998, 76, 65.
28. Baker P.N., Davidge T., Roberts M.: Plasma from women with preeclampsia increases endothelial cell NO production. Hypertension, 1995, 26, 244.
29. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B.: The role of nitric oxide in the pathogenesis o preeclampsia. Am. J. Obstet. Gynecol., 1994, 171, 944.
30. Lyall F., Young A., Geer J.A.: NO concentration are increased in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol., 1995, 173, 714.